Biotechnology Webcasts

AusBiotech is the national body for the biotechnology and life sciences industry in Australia and the quarterly PwC publication Bioforum reports on the latest updates and key challenges in this industry.

View video

AusBiotech webcast series #6 – April 2012

Craig Lawn, PwC Partner and Dr Anna Lavelle, AusBiotech, sat down to discuss the state of the biotechnology and life science sector including the impact of the R&D Tax Credit, changes in the market for capital as well as current and emerging trends.

Introduction Reflection on the past year Impact of R&D Tax Credit Changes in the market for capital Trends Conclusion

View video

AusBiotech webcast series #5 – Sep 2011

Manoj Santiago, PwC Partner and Dr Lavelle, AusBiotech, sat down to discuss the state of the biotechnology and life sciences sector, including the current climate, the future of gene patenting laws, and the future outlook of capital raising in the industry.

Introduction Reflection of the year Present benefits of R&D tax legislation changes Tax legislation going forward Lack of IPOs in a strong secondary market General investment in the industry Biotech industry in the wider social community Conclusion

View video

AusBiotech webcast series #4 – May 2011

Manoj Santiago, PwC Partner and Dr Lavelle, AusBiotech, sat down to discuss the state of the biotechnology and life sciences sector, including the current climate, proposed changes to gene patenting laws, and the government presence in the market.

Introduction Results and strategies for going forward The effects of the GFC on Capital Raising Proposed changes to practice of gene patenting Role of Govt: setting the 'tone from the top' Impact of recent Government decisions Investor sentiment in the current market Conclusion>

View video

AusBiotech webcast series #3 – Oct 2010

Craig Lawn, PwC Partner and Dr Lavelle, AusBiotech, took time out from the 2010 AusBiotech conference to discuss the biotechnology sector, what's on the horizon and growth.

Dr Lavelle discusses the state of the nation Understanding the biotechnology sector Two things that count in biotechnology What would Dr Lavelle like to grow?

Series 2:
FY10 webcast

AusBiotech webcast series #2 – Q3 FY10

Craig Lawn, PwC Partner and Dr Greg Roger, AusBiotech, met in April to discuss the biotechnology sector, what's on the horizon, how R&D changes will affect the sector and more.

Introduction Listed Companies – US vs Aus R&D Tax Changes The Market Changes in the Landscape What Could Observations Conclusion

Series 1:
FY10 webcast

AusBiotech webcast series #1 – Q1 FY10

Craig Lawn, PwC Partner and Dr Lavelle, AusBiotech CEO, met prior to the AusBiotech Conference in Melbourne, to commence the regular PwC & AusBiotech webcast update on the biotechnology sector.

Introduction Strength of the ex majors CEO confidence US activity and the strong Aussie dollar Big trends over the next six months Summary and conclusion